Market Overview

Morning Market Losers

Related PATH
Benzinga's M&A Chatter for Tuesday January 21, 2014
Teva Acquires NuPathe for $3.65/Share in Cash, Plus Up to $3.15/Share Based on Zecuity Sales
Related BTH
Benzinga's Weekend M&A Chatter
CVSL Intends to Amplify Its Proposal for Blyth

NuPathe (NASDAQ: PATH) fell 33.41% to $2.89 at 9:55 am. NuPathe has entered into agreements with existing and new investors for the sale of $28 million of securities.

Blyth (NYSE: BTH) shares dipped 18.94% to $26.40. Blyth's ViSalus subsidiary withdrew its initial public offering.

OMNOVA Solutions (NYSE: OMN) dipped 17.60% to $7.21. OMNOVA Solutions reported a surge in its net income for the third quarter. However, its net sales for the period dropped 8.5% to $288.2 million.

Catalyst Pharmaceutical Partners (NASDAQ: CPRX) dropped 14.13% to $1.58. Catalyst Pharma updated guidance on timing of top-line data from CPP-109 Phase IIB clinical trial.

Posted-In: Morning Market LosersNews Movers & Shakers Intraday Update Markets

 

Most Popular

Related Articles (CPRX + BTH)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free